1Day Africa Study Highlights R21 Vaccine as a Cost-Effective Solution to Malaria Compared to Popular Interventions
Lusaka, 26 November 2024 A groundbreaking study by 1Day Africa, the African chapter of U.S. public health nonprofit 1Day Sooner, has revealed the high cost-effectiveness of the new R21 malaria vaccine compared to existing interventions […]